Nalaganje...
Loss of B-cell translocation gene 2 expression in estrogen receptor-positive breast cancer predicts tamoxifen resistance
B-cell translocation gene 2 (BTG2), a gene suppressed in a subset of aggressive breast cancer, is repressed by estrogen. BTG2 inhibits the expression of HER ligands and promotes AKT activation, which plays an essential role in the tamoxifen resistance of estrogen receptor (ER)-positive breast cancer...
Shranjeno v:
| izdano v: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BlackWell Publishing Ltd
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4317889/ https://ncbi.nlm.nih.gov/pubmed/24698107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12410 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|